Browsing by Author "Zhang, Jennifer Y"
Results Per Page
Sort Options
Item Open Access BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization.(Cell Res, 2010-04) Ke, Hengning; Parron, Vandy I; Reece, Jeff; Zhang, Jennifer Y; Akiyama, Steven K; French, John EBCL2 is best known as a multifunctional anti-apoptotic protein. However, little is known about its role in cell-adhesive and motility events. Here, we show that BCL2 may play a role in the regulation of cell adhesion, spreading, and motility. When BCL2 was overexpressed in cultured murine and human cell lines, cell spreading, adhesion, and motility were impaired. Consistent with these results, the loss of Bcl2 resulted in higher motility observed in Bcl2-null mouse embryonic fibroblast (MEF) cells compared to wild type. The mechanism of BCL2 regulation of cell adhesion and motility may involve formation of a complex containing BCL2, actin, and gelsolin, which appears to functionally decrease the severing activity of gelsolin. We have observed that the lysate from MCF-7 and NIH3T3 cells that overexpressed BCL2 enhanced actin polymerization in cell-free in vitro assays. Confocal immunofluorescent localization of BCL2 and F-actin during spreading consistently showed that increased expression of BCL2 resulted in increased F-actin polymerization. Thus, the formation of BCL2 and gelsolin complexes (which possibly contain other proteins) appears to play a critical role in the regulation of cell adhesion and migration. Given the established correlation of cell motility with cancer metastasis, this result may explain why the expression of BCL2 in some tumor cell types reduces the potential for metastasis and is associated with improved patient prognosis.Item Open Access Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration(Frontiers in Oncology) Degan, Simone; May, Brian L; Jin, Yingai J; Hammoda, Manel Ben; Sun, Huiying; Zhang, Guoqiang; Wang, Yan; Erdmann, Detlev; Warren, Warren; Zhang, Jennifer YAutophagy is characterized as a cytoprotective process and inhibition of autophagy with medicinally active agents, such as chloroquine (CQ) is proposed as a prospective adjuvant therapy for cancer. Here, we examined the preclinical effects of CQ combined with the MEK inhibitor trametinib (TRA) on melanoma. We found that cotreatment of CQ and TRA markedly slowed melanoma growth induced in Tyr-CreER.BrafCa.Ptenfl/fl mice. Immunostaining showed that trametinib decreased Ki-67+ proliferating cells, and increased TUNEL+ apoptotic cells. The combo treatment induced a further decrease of Ki-67+ proliferating cells. Consistent with the in vivo findings, CQ and TRA inhibited melanoma cell proliferation in vitro, which was correlated by decreased cyclin D1 expression. In addition, we found that tissues treated with CQ and TRA had significantly decreased numbers of CD4+ and CD8+ T-lymphocytes and F4/80+ macrophages. Together, these results indicate that cotreatment of CQ and TRA decreases cancer cell proliferation, but also dampens immune cell infiltration. Further study is warranted to understand whether CQ-induced immune suppression inadvertently affects therapeutic benefits.Item Open Access CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.(J Invest Dermatol, 2013-01) Ke, Hengning; Augustine, Christina K; Gandham, Vineela D; Jin, Jane Y; Tyler, Douglas S; Akiyama, Steven K; Hall, Russell P; Zhang, Jennifer YThe molecular mechanisms mediating cylindromatosis (CYLD) tumor suppressor function appear to be manifold. Here, we demonstrate that, in contrast to the increased levels of phosphorylated c-Jun NH(2)-terminal kinase (pJNK), CYLD was decreased in a majority of the melanoma cell lines and tissues examined. Exogenous expression of CYLD but not its catalytically deficient mutant markedly inhibited melanoma cell proliferation and migration in vitro and subcutaneous tumor growth in vivo. In addition, the melanoma cells expressing exogenous CYLD were unable to form pulmonary tumor nodules following tail-vein injection. At the molecular level, CYLD decreased β1-integrin and inhibited pJNK induction by tumor necrosis factor-α or cell attachment to collagen IV. Moreover, CYLD induced an array of other molecular changes associated with modulation of the "malignant" phenotype, including a decreased expression of cyclin D1, N-cadherin, and nuclear Bcl3, and an increased expression of p53 and E-cadherin. Most interestingly, coexpression of the constitutively active MKK7 or c-Jun mutants with CYLD prevented the above molecular changes, and fully restored melanoma growth and metastatic potential in vivo. Our findings demonstrate that the JNK/activator protein 1 signaling pathway underlies the melanoma growth and metastasis that are associated with CYLD loss of function. Thus, restoration of CYLD and inhibition of JNK and β1-integrin function represent potential therapeutic strategies for treatment of malignant melanoma.Item Open Access FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.(Oncotarget, 2016-06-07) Zhang, Xiaoling; Wu, Joseph; Luo, Suju; Lechler, Terry; Zhang, Jennifer YFRA1 (Fos-like antigen 1) is highly expressed in many epithelial cancers including squamous cell carcinoma of the skin (cSCC) and head and neck (HNSCC). However, the functional importance and the mechanisms mediating FRA1 function in these cancers are not fully understood. Here, we demonstrate that FRA1 gene silencing in HNSCC and cSCC cells resulted in two consequences - impaired cell proliferation and migration. FRA1 regulation of cell growth was distinct from that of c-Jun, a prominent Jun group AP-1 factor. While c-Jun was required for the expression of the G1/S phase cell cycle promoter CDK4, FRA1 was essential for AKT activation and AKT-dependent expression of CyclinB1, a molecule required for G2-M progression. Exogenous expression of a constitutively active form of AKT rescued cancer cell growth defect caused by FRA1-loss. Additionally, FRA1 knockdown markedly slowed cell adhesion and migration, and conversely expression of an active FRA1 mutant (FRA1DD) expedited these processes in a JNK/c-Jun-dependent manner. Through protein and ChIP-PCR analyses, we identified KIND1, a cytoskeletal regulator of the cell adhesion molecule β1-integrin, as a novel FRA1 transcriptional target. Restoring KIND1 expression rescued migratory defects induced by FRA1 loss. In agreement with these in vitro data, HNSCC cells with FRA1 loss displayed markedly reduced rates of subcutaneous tumor growth and pulmonary metastasis. Together, these results indicate that FRA1 promotes cancer growth through AKT, and enhances cancer cell migration through JNK/c-Jun, pinpointing FRA1 as a key integrator of JNK and AKT signaling pathways and a potential therapeutic target for cSCC and HNSCC.Item Open Access Genetic Mutations and Ubiquitination in Melanoma Growth and Metastasis(2019-11-08) Zhang, Jennifer Y; Dikshit, AnushkaUpon neoplastic transformation, melanoma is intrinsically prone to metastasis, which marks the most dangerous aspect of the disease and dubs it one of the most challenging cancers to treat. BRAF/MEK oncokinase inhibitors and immunotherapies have shown considerable promise in some patients, but the clinical benefits are often short-lived due to rapid development of resistance. Recently, ubiquitination enzymes have emerged as potential therapeutic targets. These enzymes can be targeted to increase expression of tumor suppressors and impede activation of oncogenic signaling pathways mediating cell proliferation and tissue invasion. This chapter describes some of the common genetic mutations in melanoma, ubiquitinating and deubiquitinating enzymes that are linked to melanoma progression, metastasis, and therapeutic resistance.Item Open Access Human Skin Explant Preparation and Culture(BIO-PROTOCOL, 2022) Shannon, Jessica L; Kirchner, Stephen J; Zhang, Jennifer YItem Open Access In vivo and ex vivo epi-mode pump-probe imaging of melanin and microvasculature.(Biomed Opt Express, 2011-06-01) Matthews, Thomas E; Wilson, Jesse W; Degan, Simone; Simpson, Mary Jane; Jin, Jane Y; Zhang, Jennifer Y; Warren, Warren SWe performed epi-mode pump-probe imaging of melanin in excised human pigmented lesions and both hemoglobin and melanin in live xenograft mouse melanoma models to depths greater than 100 µm. Eumelanin and pheomelanin images, which have been previously demonstrated to differentiate melanoma from benign lesions, were acquired at the dermal-epidermal junction with cellular resolution and modest optical powers (down to 15 mW). We imaged dermal microvasculature with the same wavelengths, allowing simultaneous acquisition of melanin, hemoglobin and multiphoton autofluorescence images. Molecular pump-probe imaging of melanocytes, skin structure and microvessels allows comprehensive, non-invasive characterization of pigmented lesions.Item Open Access Printing amphotericin B on microneedles using matrix-assisted pulsed laser evaporation.(International journal of bioprinting, 2017-01) Sachan, Roger; Jaipan, Panupong; Zhang, Jennifer Y; Degan, Simone; Erdmann, Detlev; Tedesco, Jonathan; Vanderwal, Lyndsi; Stafslien, Shane J; Negut, Irina; Visan, Anita; Dorcioman, Gabriela; Socol, Gabriel; Cristescu, Rodica; Chrisey, Douglas B; Narayan, Roger JTransdermal delivery of amphotericin B, a pharmacological agent with activity against fungi and parasitic protozoa, is a challenge since amphotericin B exhibits poor solubility in aqueous solutions at physiologic pH values. In this study, we have used a laser-based printing approach known as matrix-assisted pulsed laser evaporation to print amphotericin B on the surfaces of polyglycolic acid microneedles that were prepared using a combination of injection molding and drawing lithography. In a modified agar disk diffusion assay, the amphotericin B-loaded microneedles showed concentration-dependent activity against the yeast Candida albicans. The results of this study suggest that matrix-assisted pulsed laser evaporation may be used to print amphotericin B and other drugs that have complex solubility issues on the surfaces of microneedles.Item Open Access RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation.(J Invest Dermatol, 2015-04) Zhang, Xiaoling; Jin, Jane Y; Wu, Joseph; Qin, Xiaoxia; Streilein, Robert; Hall, Russell P; Zhang, Jennifer YMice with epidermal deletion of JunB transcription factor displayed a psoriasis-like inflammation. The relevance of these findings to humans and the mechanisms mediating JunB function are not fully understood. Here we demonstrate that impaired JunB function via gene silencing or overexpression of a dominant negative mutant increased human keratinocyte cell proliferation but decreased cell barrier function. RNA-seq revealed over 500 genes affected by JunB loss of function, which included the upregulation of an array of proinflammatory molecules relevant to psoriasis. Among these were tumor necrosis factor α (TNFα), CCL2, CXCL10, IL6R, and SQSTM1, an adaptor protein involved in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Chromatin immunoprecipitation (ChIP)-Seq and gene reporter analyses showed that JunB directly suppressed SQSTM1 by binding to a consensus AP-1 cis element located around 2 kb upstream of SQSTM1-transcription start site. Similar to JunB loss of function, SQSTM1-overexpression induced TNFα, CCL2, and CXCL10. Conversely, NF-κB inhibition genetically with a mutant IκBα or pharmacologically with pyrrolidine dithiocarbamate (PDTC) prevented cytokine, but not IL6R, induction by JunB deficiency. Taken together, our findings indicate that JunB controls epidermal growth, barrier formation, and proinflammatory responses through direct and indirect mechanisms, pinpointing SQSTM1 as a key mediator of JunB suppression of NF-κB-dependent inflammation.Item Open Access Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.(JCI insight, 2023-06) Poe, Jonathan C; Fang, Jiyuan; Zhang, Dadong; Lee, Marissa R; DiCioccio, Rachel A; Su, Hsuan; Qin, Xiaodi; Zhang, Jennifer Y; Visentin, Jonathan; Bracken, Sonali J; Ho, Vincent T; Wang, Kathy S; Rose, Jeremy J; Pavletic, Steven Z; Hakim, Frances T; Jia, Wei; Suthers, Amy N; Curry-Chisolm, Itaevia M; Horwitz, Mitchell E; Rizzieri, David A; McManigle, William C; Chao, Nelson J; Cardones, Adela R; Xie, Jichun; Owzar, Kouros; Sarantopoulos, StefanieAlloreactivity can drive autoimmune syndromes. After allogeneic hematopoietic stem cell transplantation (allo-HCT), chronic graft-versus-host disease (cGVHD), a B cell-associated autoimmune-like syndrome, commonly occurs. Because donor-derived B cells continually develop under selective pressure from host alloantigens, aberrant B cell receptor (BCR) activation and IgG production can emerge and contribute to cGVHD pathobiology. To better understand molecular programing of B cells in allo-HCT, we performed scRNA-Seq analysis on high numbers of purified B cells from patients. An unsupervised analysis revealed 10 clusters, distinguishable by signature genes for maturation, activation, and memory. Within the memory B cell compartment, we found striking transcriptional differences in allo-HCT patients compared with healthy or infected individuals, including potentially pathogenic atypical B cells (ABCs) that were expanded in active cGVHD. To identify intrinsic alterations in potentially pathological B cells, we interrogated all clusters for differentially expressed genes (DEGs) in active cGVHD versus patients who never had signs of immune tolerance loss (no cGVHD). Active cGVHD DEGs occurred in both naive and BCR-activated B cell clusters. Remarkably, some DEGs occurred across most clusters, suggesting common molecular programs that may promote B cell plasticity. Our study of human allo-HCT and cGVHD provides understanding of altered B cell memory during chronic alloantigen stimulation.Item Open Access Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With M1 Macrophage Polarization in Hidradenitis Suppurativa.(Frontiers in medicine, 2021-01) Mariottoni, Paula; Jiang, Simon W; Prestwood, Courtney A; Jain, Vaibhav; Suwanpradid, Jutamas; Whitley, Melodi Javid; Coates, Margaret; Brown, David A; Erdmann, Detlev; Corcoran, David L; Gregory, Simon G; Jaleel, Tarannum; Zhang, Jennifer Y; Harris-Tryon, Tamia A; MacLeod, Amanda SHidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent abscesses, nodules, and sinus tracts in areas of high hair follicle and sweat gland density. These sinus tracts can present with purulent drainage and scar formation. Dysregulation of multiple immune pathways drives the complexity of HS pathogenesis and may account for the heterogeneity of treatment response in HS patients. Using transcriptomic approaches, including single-cell sequencing and protein analysis, we here characterize the innate inflammatory landscape of HS lesions. We identified a shared upregulation of genes involved in interferon (IFN) and antimicrobial defense signaling through transcriptomic overlap analysis of differentially expressed genes (DEGs) in datasets from HS skin, diabetic foot ulcers (DFUs), and the inflammatory stage of normal healing wounds. Overlap analysis between HS- and DFU-specific DEGs revealed an enrichment of gene signatures associated with monocyte/macrophage functions. Single-cell RNA sequencing further revealed monocytes/macrophages with polarization toward a pro-inflammatory M1-like phenotype and increased effector function, including antiviral immunity, phagocytosis, respiratory burst, and antibody-dependent cellular cytotoxicity. Specifically, we identified the STAT1/IFN-signaling axis and the associated IFN-stimulated genes as central players in monocyte/macrophage dysregulation. Our data indicate that monocytes/macrophages are a potential pivotal player in HS pathogenesis and their pathways may serve as therapeutic targets and biomarkers in HS treatment.Item Open Access The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.(Cells, 2020-04-02) Hammouda, Manel B; Ford, Amy E; Liu, Yuan; Zhang, Jennifer YThe c-Jun N-terminal kinases (JNKs), with its members JNK1, JNK2, and JNK3, is a subfamily of (MAPK) mitogen-activated protein kinases. JNK signaling regulates a wide range of cellular processes, including cell proliferation, differentiation, survival, apoptosis, and inflammation. Dysregulation of JNK pathway is associated with a wide range of immune disorders and cancer. Our objective is to provide a review of JNK proteins and their upstream regulators and downstream effector molecules in common skin disorders, including psoriasis, dermal fibrosis, scleroderma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.Item Open Access Thymic Stromal Lymphopoietin Controls Hair Growth(2022) Shannon, Jessica LynneSkin is the largest organ and primary barrier to the external environment. Functionally distinct tissues maintain the skin barrier under homeostatic conditions to protect underlying organs from water loss, UV radiation, noxious chemicals, mechanical pressure, and infectious pathogens. Protection from these challenges is dependent on dialogue between tissue-resident stem cells and heterologous cell populations in a microenvironment or “niche” to coordinate tissue regeneration throughout life. Hair follicles (HFs) are a defining feature of mammals and represent one of few mammalian tissues with complete regenerative capabilities. HF niche environments are specialized centers that are populated by heterologous cell types spanning many lineages. HFs contain harbor a reservoir of hair follicle stem cells (HFSCs) that are central to regenerative activity of the niche. Unlike stem cells in bone marrow, intestinal epithelium, and interfollicular epidermis, HFSC expressing Lgr5 are largely quiescent; HFSC activity is temporally restricted to episodic bouts of proliferation and differentiation as a primary means to preserve stem cell integrity. Lgr5+ HFSC are multipotent stem cells and can regenerate all cellular lineages of the epidermis, hair follicle, and sebaceous gland; this potency is powerful during homeostatic HF regeneration and during wound repair. Tissue regeneration after injury prompts the local production and integration of signals by local cells including epithelial cells and HFSCs to communicate with each other and to coordinate early stages of tissue regeneration. Damage to the epidermal barrier stimulates local follicles to produce a new hair shaft, a process termed wound-induced hair growth (WIHG). Despite advances in our understanding of HF niche dynamics, it is unclear how specific wound-derived factors modulate stem cell and immune activity to couple wound healing with hair growth. We discovered the cytokine, thymic stromal lymphopoietin (TSLP) is produced in response to skin injury and during the anagen stage of the hair follicle cycle. We generated animal models of skin tissue regeneration and observed that exogenous TSLP is a potent inducer of hair growth during normal hair growth cycles and after skin injury. Interestingly, we found that TSLP treatment may have lasting effects to the tissue to favor hair follicle regeneration. TSLP-treated wound beds only showed accelerated WIHG onset and shortened quiescence phase prior to the next hair cycle. Using flow cytometry and fluorescent immunostaining, we examined TSLP functions in the skin to find that TSLP promotes the activation and proliferation of HFSC. HFSC activation results in generation of transit amplifying cells required for tissue regeneration, functionally linking TSLP to tissue regeneration during hair growth and during wound healing. We used in vitro and ex vivo models to determine how our findings translated to human tissue. We designed reagents to discriminate between unique expressed variants in human and confirmed that only the full length TSLP variant (long form, lfTSLP) that shares functional homology with murine TSLP was upregulated after injury in human skin. Consistent with findings from other groups, we report that lfTSLP promoted proliferation and reduced expression of differentiation genes in primary human epidermal keratinocytes. To determine the functional requirement for TSLPR in HFSC, we generated a mouse model enabling spatial and temporal control of Tslpr gene expression in LGR5+ HFSC. Tslpr ablation in adult skin inhibited both wound-induced and exogenous TSLP-induced hair growth. Additionally, Tslpr ablation during postnatal development resulted in severely delayed generation of the fur coat. Interestingly, Tslpr ablation did not reduce the LGR5+ HFSC population, indicating that TSLPR is not required for stem cell survival in the skin. Exogenous TSLP treatment increased expression of the epidermal progenitor factor DDX6 and the cell cycle regulator cyclin D1 in a TSLPR-dependent manner, highlighting a novel function for TSLP in regulation of hair follicle activity during homeostasis and during wound healing. Together, these findings delineate TSLP as a novel and locally produced cytokine that directly stimulates hair follicle cell proliferation in the skin during development and during tissue regeneration after injury. Immune cells have potent roles to regulate HFSC activity during hair follicle regeneration during hair growth and after skin injury. In epithelial tissues, TSLP has potent immunomodulatory functions and can unleash pathogenic Type-2 immune responses. Using flow cytometry, we observed mouse skin treated with TSLP appeared largely normal, with no significant changes in immune cell distribution. However, mice lacking Tslpr on LGR5+ HFSC exhibited a two-fold increase in cutaneous immune cells, with minimal changes in the number of dendritic epidermal T cells, the most abundant immune cell population in mouse skin. Instead, we observed a significant increase in CD8+ cell abundance, irregular CD8+ cell distribution, and irregular hair follicle morphology. These results suggest a tissue-specific and pleiotropic function for TSLP to facilitate niche communications during tissue regeneration.
Item Open Access Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch.(J Biol Chem, 2016-05-06) Chen, Yong; Fang, Quan; Wang, Zilong; Zhang, Jennifer Y; MacLeod, Amanda S; Hall, Russell P; Liedtke, Wolfgang BTRPV4 ion channels function in epidermal keratinocytes and in innervating sensory neurons; however, the contribution of the channel in either cell to neurosensory function remains to be elucidated. We recently reported TRPV4 as a critical component of the keratinocyte machinery that responds to ultraviolet B (UVB) and functions critically to convert the keratinocyte into a pain-generator cell after excess UVB exposure. One key mechanism in keratinocytes was increased expression and secretion of endothelin-1, which is also a known pruritogen. Here we address the question of whether TRPV4 in skin keratinocytes functions in itch, as a particular form of "forefront" signaling in non-neural cells. Our results support this novel concept based on attenuated scratching behavior in response to histaminergic (histamine, compound 48/80, endothelin-1), not non-histaminergic (chloroquine) pruritogens in Trpv4 keratinocyte-specific and inducible knock-out mice. We demonstrate that keratinocytes rely on TRPV4 for calcium influx in response to histaminergic pruritogens. TRPV4 activation in keratinocytes evokes phosphorylation of mitogen-activated protein kinase, ERK, for histaminergic pruritogens. This finding is relevant because we observed robust anti-pruritic effects with topical applications of selective inhibitors for TRPV4 and also for MEK, the kinase upstream of ERK, suggesting that calcium influx via TRPV4 in keratinocytes leads to ERK-phosphorylation, which in turn rapidly converts the keratinocyte into an organismal itch-generator cell. In support of this concept we found that scratching behavior, evoked by direct intradermal activation of TRPV4, was critically dependent on TRPV4 expression in keratinocytes. Thus, TRPV4 functions as a pruriceptor-TRP in skin keratinocytes in histaminergic itch, a novel basic concept with translational-medical relevance.